← Open Payments lookup

MATTHEW FRANZ: Open Payments

NPI 1669055166 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$941 in 33 payments from 15 companies in 2025. Trend: 2023 $281 · 2024 $441 · 2025 $941

Food & beverage: $902Education: $39
CompanyPaymentsAmount
Janssen Biotech, Inc.8$219
Takeda Pharmaceuticals U.S.A., Inc.8$147
GENZYME CORPORATION1$125
EVOKE PHARMA, INC.1$125
Lilly USA, LLC3$80
Regeneron Healthcare Solutions, Inc.2$60
QOL Medical, LLC2$46
Celltrion USA Inc.1$22
Aimmune Therapeutics, Inc.1$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$21

Products named: TREMFYA, DUPIXENT, GIMOTI, EOHILIA, OMVOH, ENTYVIO, Sucraid, VEGZELMA.

Industry payments across MI — which companies pay providers there.